Sheela Shrestha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sheela Shrestha has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Lauren M. Pachman
Division of Pediatric Rheumatology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA
2 shared publications - Adele L. Boskey
Musculoskeletal Integrity Program, Hospital for Special Surgery, New York, NY, USA
1 shared publication - Annette L. Urganus
Center of Excellence in Clinical Immunology, Children’s Memorial Research Center, Chicago, USA
1 shared publication - Heather Gordish-Dressman
Center for Genetic Medicine, Children’s National Health System & the George Washington, Washington, DC, USA
1 shared publication - Lyudmila Spevak
Mineralized Tissues Laboratory, Hospital for Special Surgery, New York, NY, United States
1 shared publication - Nicholas S. Geraci
Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN, USA
1 shared publication
Latest Publications
- 20 August 2009
- Published by Springer Nature in Calcified Tissue International
- Vol. 85 (3) , 267-275
Characterization of Dystrophic Calcification Induced in Mice by Cardiotoxin
Dystrophic calcifications often occur after injury, infection, or onset of certain rheumatic diseases. Treatment has been limited to surgical removal following failure of medical therapy. In an attempt to establish a reproducible animal model for dystrophic calcification that permitted the screening of potential interventions, we evaluated cardiotoxin (injury)-induced calcifications in three murine strains at both the cellular and ultrastructural levels. All osteopontin null mice and tumor necrosis factor receptor null mice on a C57B6 background had calcifications at days 3 and 7 after injury compared to 75% of wild-type C57B6 mice. There was no difference in mineral content among calcifications from the three mouse strains. Osteogenesis was suggested by the expression of osteocalcin, osterix, and alkaline phosphatase in calcified murine muscle tissue. Osteoclast-like cells facilitated the removal of transient dystrophic deposits (<28 days) in all models. However, none of the models showed an association of mineral crystals with collagen, suggesting that the deposits were not bone-like. The dystrophic mechanism was validated as cell death, and mitochondrial calcifications occurred soon after skeletal muscle injury in the three murine strains.
- 20 August 2009
- Published by Springer Nature in Calcified Tissue International
- Vol. 85 (3) , 267-275
Characterization of Dystrophic Calcification Induced in Mice by Cardiotoxin
Dystrophic calcifications often occur after injury, infection, or onset of certain rheumatic diseases. Treatment has been limited to surgical removal following failure of medical therapy. In an attempt to establish a reproducible animal model for dystrophic calcification that permitted the screening of potential interventions, we evaluated cardiotoxin (injury)-induced calcifications in three murine strains at both the cellular and ultrastructural levels. All osteopontin null mice and tumor necrosis factor receptor null mice on a C57B6 background had calcifications at days 3 and 7 after injury compared to 75% of wild-type C57B6 mice. There was no difference in mineral content among calcifications from the three mouse strains. Osteogenesis was suggested by the expression of osteocalcin, osterix, and alkaline phosphatase in calcified murine muscle tissue. Osteoclast-like cells facilitated the removal of transient dystrophic deposits (<28 days) in all models. However, none of the models showed an association of mineral crystals with collagen, suggesting that the deposits were not bone-like. The dystrophic mechanism was validated as cell death, and mitochondrial calcifications occurred soon after skeletal muscle injury in the three murine strains.
- Open Access
- 1 January 2008
- Published by Springer Nature in BMC Immunology
- Vol. 9 (1) , 43
Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
To evaluate the impact of the duration of chronic inflammation on gene expression in skeletal muscle biopsies (MBx) from untreated children with juvenile dermatomyositis (JDM) and identify genes and biological processes associated with the disease progression, expression profiling data from 16 girls with active symptoms of JDM greater than or equal to 2 months were compared with 3 girls with active symptoms less than 2 months.
- 1 January 2008
- Published by Springer Nature in BMC Immunology
- Vol. 9 (1) , 43
Open AccessDuration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
To evaluate the impact of the duration of chronic inflammation on gene expression in skeletal muscle biopsies (MBx) from untreated children with juvenile dermatomyositis (JDM) and identify genes and biological processes associated with the disease progression, expression profiling data from 16 girls with active symptoms of JDM greater than or equal to 2 months were compared with 3 girls with active symptoms less than 2 months.